6. Tracking immunotherapy response with single cell T cell receptor profiling in canine models of cancer

Spontaneous cancers in companion dogs are increasingly recognized as robust models of human disease. The ability to track tumor-specific immune responses in these models would benefit from reagents to perform species-specific single cell T cell receptor sequencing (scTCRseq). To date, scTCRseq and its integration with scRNA data have not been demonstrated for canine samples. Five healthy dogs, two dogs with T cell lymphoma and four dogs with melanoma in a trial of an autologous deglycosylated melanoma vaccine were selected to demonstrate applicability of scTCRseq in a cancer immunotherapy setting.
Source: Cancer Genetics and Cytogenetics - Category: Genetics & Stem Cells Authors: Source Type: research